Akcea Therapeutics (AKCA) Misses Q4 EPS by 6c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/31/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. DASH
9. GILD
10. SBUX

Go back to Akcea Therapeutics (AKCA) Misses Q4 EPS by 6c

Akcea Reports Financial Results and Highlights for Fourth Quarter and Year End 2018

February 26, 2019 4:06 PM EST

TEGSEDI (inotersen) commercially available in United States, European Union & Canada

Achieved Fourth Quarter 2018 TEGSEDI® (inotersen) Global Net Product Revenues of $2.2 Million

Conference Call Webcast Tuesday, February 26, 4:30 p.m. ET at www.akceatx.com 

BOSTON, Feb. 26, 2019 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (NASDAQ: AKCA), an affiliate of Ionis Pharmaceuticals, Inc., focused on developing... More